Metal and metal oxide nanoparticles are reshaping advanced drug delivery systems and medical devices with their unique properties and versatile platforms for targeted interventions and diagnostic imaging.
In the dynamic landscape of nanomedicine, metal-based and inorganic nanoparticles emerge as pioneers, reshaping the possibilities of advanced drug delivery systems and medical devices.
Engineered from materials such as gold, silver, iron oxide and silica, inorganic nanoparticles bring a unique set of properties to the forefront of nanomedicine. These nanoparticles offer a versatile platform for targeted drug delivery, diagnostic imaging and therapeutic interventions.
Inorganic nanoparticles frequently have their surfaces coated with a broad modality of organic small molecules or polymers, which provide biocompatibility, enhanced stability and opportunities for specific surface functionalization chemistry and introduction of active payloads and targeting handles.
The application of inorganic nanoparticles provides access to unique physicochemical properties such as high surface area per unit volume and unique optical and magnetic properties.
Inorganic nanoparticles can be functionalized with various specific ligands to enhance their affinity towards target cells or molecules.
Our Ardena team of metal nanoparticle experts can craft your inorganic nanoparticles. Leveraging our in-depth knowledge and hands-on experience, we offer a spectrum of solutions to bring your drug delivery projects to fruition.
We have extensive experience creating inorganic nanoparticles, producing a wide variety of materials, such as metal and metal-oxide nanoparticles, silica- and silicate-based nanoparticles and other modalities.
The Ardena team of analytical experts is experienced with the analytical method development for, and characterization of, various metal- or metal-oxide-based nanoparticles such as iron-oxide and silica nanoparticles. Within our analytical laboratories, we employ various techniques to quantify and characterize the inorganic core, as well as the coatings (e.g., polymer, lipids) and different types of APIs, such as small-molecule drugs, oligonucleotides and peptides.
Additionally, we use orthogonal techniques to measure critical nanoparticle properties such as particle size distribution and morphology. This comprehensive approach ensures thorough characterization and optimization of metal and metal-oxide nanoparticle formulations.
At Ardena, we stay at the forefront of technological advancements, continuously innovating to provide state-of-the-art solutions tailored to your unique project requirements. We value collaboration and work closely with clients to understand their needs and deliver the desired inorganic nanoparticle solutions.
Our commitment to excellence is evident in our successful track record with inorganic nanoparticles. Ardena has played a pivotal role in advancing numerous projects, including:
Our expert team members share their deep, scientific understanding and insights into nanomedicine development and manufacturing.
Discuss your project and learn more about how we can bring your innovative inorganic nanoparticle project to life.